John E Levine
Video Visit Available
Accepting New Patients
Mount Sinai Verified Doctors IconMount Sinai DoctorsTreats Children & Adults

John E Levine, MD

Pediatrics, Pediatric Hematology-Oncology

No Patient Experience Ratings
White Phone Icon212-241-6021
Calender Icon
Book an Appointment
White Right Arrow

About Me

John Levine, MD, MS is the Co-Director of the Mount Sinai Acute GVHD International Consortium (MAGIC) and Director of BMT Clinical Research at the Tisch Cancer Institute and a Professor of Internal Medicine and Pediatrics at the Icahn School of Medicine at Mount Sinai. His research program focused on allogeneic hematopoietic cell transplantation with an emphasis on improving outcomes for patients with graft-versus-host disease (GVHD). The centerpiece of Dr. Levine’s research is the MAGIC program, a collaborative effort among over 20 centers in North America, Europe, and Asia, that prospectively studies adult and pediatric recipients of an allogeneic HCT and contains the world’s largest data collection and biorepository dedicated to understanding the biology and clinical course of GVHD. Dr. Levine led the MAGIC effort that created the new international standard for clinical GVHD staging and grading and together with his laboratory collaborator, Dr. James Ferrara, they invented a biomarker blood test that accurately predicts outcomes for patients who require treatment for GVHD. This work has since been translated into clinical trials that test risk-adapted treatments to improve responses and decrease toxicity of GVHD therapy. In addition to his own research program, Dr. Levine has provided leadership to the field as the Chair of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) from 2024-2025 and the Chair of the Cellular Therapy Committee for Children’s Oncology Group (2016-2023).

Language
English
Position
PROFESSOR | Medicine, Hematology and Medical Oncology, PROFESSOR | Pediatrics
Hospital Affiliations
  • Mount Sinai Queens
  • The Mount Sinai Hospital
Research Topics

Translational Research, Transplantation